Class Action Filed Against Zynex, Inc. (ZYXIQ) - April 21, 2026 Deadline to Join

Core Viewpoint - A class action securities lawsuit has been filed against Zynex, Inc. for alleged securities fraud affecting investors between February 25, 2021, and December 15, 2025 [1] Group 1: Allegations and Company Practices - The lawsuit alleges that Zynex shipped products, including electrodes, in excess of need, inflating its revenue [2] - It is claimed that Zynex's practice of filing false claims drew scrutiny from insurers, including the health insurance program, Tricare [2] - Travelers initiated an action against Zynex and its executives, alleging a fraudulent overbilling scheme and seeking over $23 million in damages related to hundreds of fraudulent claims from 2018 to 2023 [2] - The management prioritized aggressive sales strategies over compliance with industry laws, leading to illegal overbilling practices [2] - The audit committee allegedly acted with reckless disregard for the underlying fraud, helping to bolster the Company's stock price through stock repurchase plans [2] Group 2: Legal Process and Participation - Investors who suffered losses in Zynex, Inc. during the relevant time frame have until April 21, 2026, to request to be appointed as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a track record of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]